20/20 Biolabs, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $3.6M
Liabilities Breakdown FY2024
Total Liabilities: $2.1M
Asset Breakdown
Total Assets: $3.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.8M | 49.8% |
| Accounts Receivable | $135.3K | 3.8% |
| Inventory | $47.2K | 1.3% |
| Property, Plant & Equipment | $116.7K | 3.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $205.5K | 5.7% |
| Other Assets | $1.3M | 36.2% |
Liabilities Breakdown
Total Liabilities: $2.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $372.3K | 17.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.7M | 82.1% |